AOD-9604 is a synthetic 16-amino-acid peptide modeled on the C-terminal region of the human growth-hormone (hGH) molecule, specifically the hGH(177-191) fragment with an added N-terminal tyrosine. It is studied in preclinical research as a tool compound for investigating fat-metabolism and lipid-pathway signaling in research models, independent of the full growth-hormone molecule’s receptor activity.
AOD-9604 is a fully synthetic fragment analog and does not occur natively in this form. As supplied for research, it is a lyophilized powder that is water-soluble on reconstitution.
Verified dataVerified compound data
| Property | Value |
|---|---|
| Compound name | AOD-9604 (hGH 177-191 fragment analog, Tyr-modified) |
| CAS number | 221231-10-3 |
| PubChem CID | 71300630 (free base); 168310522 (acetate) |
| Molecular formula | C78H123N23O23S2 |
| Molecular weight | ~1815.10 g/mol |
| Length | 16 residues (hGH(177-191) + N-terminal Tyr) |
| Physical form | Lyophilized powder |
Data verified against PubChem (CID 71300630 free base / CID 168310522 acetate, both C78H123N23O23S2, MW ~1815.1) and Wikipedia (CAS 221231-10-3, MW 1815.10). The acetate-salt record carries the same backbone formula; values above reflect the peptide.
MechanismResearch-context mechanism
In preclinical literature, AOD-9604 is studied as a growth-hormone-fragment analog that, in research models, is investigated for its association with lipid-metabolism and lipolytic signaling pathways. Research has examined the fragment in the context of fat-cell metabolism studies in vitro and in animal models, distinct from the growth-promoting and receptor activities of the full hGH molecule. These mechanisms are described strictly in a research-model context; they are not established human-use mechanisms.
Research summaryCurrent research summary
AOD-9604 appears across preclinical literature as a growth-hormone-fragment research tool. Reported research areas include:
- Lipid-metabolism and lipolysis pathway studies (cell and animal models)
- Fat-cell (adipocyte) metabolism research models
- Comparative studies vs the full hGH molecule’s activity (preclinical)
- Metabolic-signaling research models
The existing body of work is predominantly in vitro and animal. AOD-9604 is not an FDA-approved drug and has no established human therapeutic use. All framing here is strictly laboratory research.
QuestionsFrequently Asked Questions
What is AOD-9604?
AOD-9604 is a synthetic 16-amino-acid peptide modeled on the hGH(177-191) fragment of the human growth-hormone molecule, studied in preclinical metabolic-pathway research models. It is a research compound supplied as a lyophilized powder and is not approved for human use.
What is the molecular formula of AOD-9604?
The molecular formula of AOD-9604 is C78H123N23O23S2, with a molecular weight of approximately 1815.10 g/mol (PubChem CID 71300630).
What is the CAS number for AOD-9604?
The CAS registry number for AOD-9604 is 221231-10-3.
What is AOD-9604 derived from?
AOD-9604 is a synthetic analog of the C-terminal hGH(177-191) fragment of the human growth-hormone molecule, with an added N-terminal tyrosine residue. It is studied as a fragment tool compound, not as the full growth-hormone molecule.
How is AOD-9604 stored and reconstituted in a research setting?
Lyophilized AOD-9604 is stored at 2 to 8°C, protected from light and humidity. It is reconstituted with a suitable sterile solvent, is water-soluble, and reconstituted material is held at 4°C and used within about 30 days, avoiding repeated freeze-thaw cycles.
Is AOD-9604 approved for human use?
No. AOD-9604 is not an FDA-approved drug and is not intended for human consumption. It is offered strictly as a research compound for laboratory use.
For research use only. Not for human or veterinary use. Not approved by the FDA. 21+
- HPLC + MS tested, every batch
- U.S. synthesized
- Batch COA on the product page
$92View compound